Veterinary vaccination enhances the health of animals, so improving their life expectations. most typical veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. various diseases such as foot-and-mouth disease and influenza adversely have an effect on livestock across the world. To combat increasing prevalence of potentially fatal veterinary diseases, there’s a for vaccines. laws also are focusing on improving stability, consistency and quality of vaccines produced.
How Big is The Global Veterinary/Animal Vaccines Market?
The Veterinary/Animal Vaccines Market is expected to be around US$ 11 Billion by 2028 at a CAGR of 5.5% in the given forecast period.
The major driving factors of Veterinary/Animal Vaccines Market are as follows:
The major restraints factors of Veterinary/Animal Vaccines Market are as follows:
The Veterinary/Animal Vaccines Market has been segmented as below:
By Type:
By Disease:
By Technology:
The Veterinary/Animal Vaccines Market is segmented on the lines of its type, disease, technology and regional. Based on type it covers Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Companion Animal Vaccines, Aquaculture Vaccines and Other Animal Vaccines. Based on disease type it covers Porcine Diseases, Poultry Diseases, Livestock Diseases, Companion Animal Diseases, Aquaculture Diseases and Other Diseases. Based on technology it covers Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines and Other Vaccines. The Veterinary/Animal Vaccines Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Veterinary/Animal Vaccines Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Veterinary/Animal Vaccines Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Report Scope:
The scope of the report includes a detailed study of Veterinary/Animal Vaccines Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac, Vetoquinol, Phibro Animal Health, Hester, Hipra, Idt Biologika, Biogenesis Bago, Tianjin Ringpu and China Animal Husbandry. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Veterinary/Animal Vaccines Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Veterinary/Animal Vaccines Market.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Laboratory Information Management System Market
Kitasamycin (CAS 69-23-8) Market
1. Introduction
1.1 Key Findings
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Data
2.2 Market Size Estimation and Data Triangulation
2.3 Research Assumptions
3. Summary with Insights
4. Market Overview
4.1 Introduction
4.2 Drivers
4.3 Restraints
4.4 Industry Trends
4.5 Porter’s Five Forces Analysis
5. Veterinary/Animal Vaccines Market Analysis, By Type
5.1 Porcine Vaccines
5.2 Poultry Vaccines
5.3 Livestock Vaccines
5.3.1 Bovine Vaccines
5.3.2 Small Ruminant Vaccines
5.4 Companion Animal Vaccines
5.4.1 Canine Vaccines
5.4.2 Feline Vaccines
5.5 Aquaculture Vaccines
5.6 Other Animal Vaccines
6. Veterinary/Animal Vaccines Market Analysis, By Disease
6.1 Porcine Diseases
6.2 Poultry Diseases
6.3 Livestock Diseases
6.3.1 Bovine Diseases
6.3.2 Small Ruminant Diseases
6.4 Companion Animal Diseases
6.4.1 Canine Diseases
6.4.2 Feline Diseases
6.5 Aquaculture Diseases
6.6 Other Diseases
7. Veterinary/Animal Vaccines Market Analysis, By Technology
7.1 Live Attenuated Vaccines
7.2 Inactivated Vaccines
7.3 Toxoid Vaccines
7.4 Recombinant Vaccines
7.5 Other Vaccines
8. Veterinary/Animal Vaccines Market Analysis, By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Rest of the World
9. Competitive Overview
9.1 Introduction
9.2 New Product Launches
9.3 Acquisitions
9.4 Agreements, Partnerships, And Collaborations
9.5 Expansions
10. Company Profiles
10.1 Merck Animal Health
10.2 Hipra
10.3 Zoetis
10.4 Ceva
10.5 Virbac
10.6 Boehringer Ingelheim
10.7 Elanco
10.8 Vetoquinol
10.9 China Animal Husbandry
10.10 Idt Biologika
10.11 Biogenesis Bago
10.12 Phibro Animal Health
10.13 Hester
10.14 Tianjin Ringpu
The Veterinary/Animal Vaccines Market has been segmented as below:
By Type:
By Disease:
By Technology:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
